Profilo
Ronald R.
Dilling is currently the Chief Executive Officer at Bioresource Technology, LLC.
Prior to this, he held positions as Managing Director-Manufacturing Operations at Serologicals Corp., Operations Director at Hazelton Biologics, Inc., Vice President-Operations at SeraCare Life Sciences, Inc., and Manager-Production Laboratories at Gibco Laboratories.
Posizioni attive di Ronald R. Dilling
| Società | Posizione | Inizio |
|---|---|---|
Bioresource Technology, LLC
Bioresource Technology, LLC Medical SpecialtiesHealth Technology Manufactures and supplies IVD products | Amministratore Delegato | - |
Precedenti posizioni note di Ronald R. Dilling
| Società | Posizione | Fine |
|---|---|---|
Serologicals Corp.
Serologicals Corp. Miscellaneous Commercial ServicesCommercial Services Researches, develops and markets biological products | Corporate Officer/Principal | - |
Hazelton Biologics, Inc. | Direttore operativo | - |
Gibco Laboratories | Corporate Officer/Principal | - |
SeraCare Life Sciences, Inc.
SeraCare Life Sciences, Inc. Medical SpecialtiesHealth Technology Develops and manufactures biological based products to serve the global life sciences industry | Direttore operativo | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Serologicals Corp.
Serologicals Corp. Miscellaneous Commercial ServicesCommercial Services Researches, develops and markets biological products | Commercial Services |
SeraCare Life Sciences, Inc.
SeraCare Life Sciences, Inc. Medical SpecialtiesHealth Technology Develops and manufactures biological based products to serve the global life sciences industry | Health Technology |
Hazelton Biologics, Inc. | |
Gibco Laboratories | |
Bioresource Technology, LLC
Bioresource Technology, LLC Medical SpecialtiesHealth Technology Manufactures and supplies IVD products | Health Technology |
















